Peptide Profile

MOTS-c

Mitochondrial Open Reading Frame of the 12S rRNA-c

Research Only10 sourcesShop MOTS-c

Overview

Composition

16-amino-acid cyclic peptide encoded directly within the mitochondrial genome (mitochondrial 12S rRNA region)

Mechanism of Action

Functions as a signaling molecule that regulates metabolic homeostasis by enhancing insulin sensitivity, optimizing glucose uptake, boosting mitochondrial biogenesis and function, and influencing energy expenditure

Primary Effects

Studied for metabolic-stress signaling, insulin sensitivity, exercise-like adaptations, inflammatory pathways, and aging-associated metabolic changes, mostly in preclinical systems

Discovery & Background

Identified in the early 2010s by researchers exploring mitochondrial-encoded peptides and their extramitochondrial roles in systemic metabolism

Unlike most peptides derived from nuclear DNA, MOTS-c originates from the mitochondrial 12S rRNA region, highlighting mitochondria's active participation in nuclear gene regulation and whole-body metabolic control; early work demonstrated its ability to translocate to the nucleus under metabolic stress, modulating gene expression related to energy balance, fat metabolism, and insulin action

Not approved by regulatory agencies (e.g., FDA) for any therapeutic use; remains a research compound with sparse human data

Research Overview

Foundation of knowledge comes from animal models (mice, cell cultures), showing improvements in insulin sensitivity, protection against diet-induced obesity, enhanced fatty acid oxidation, increased AMPK activation, and better mitochondrial efficiency

01
Appears to mimic some exercise-like metabolic adaptations
02
Human data are sparse—mostly observational correlations (e.g., lower circulating MOTS-c in obese or diabetic individuals)
03
Small interventional studies suggest metabolic effects, but results are not enough to establish therapeutic use
04
No large-scale, randomized controlled trials exist
05
Interest persists due to its mitochondrial origin and broad metabolic signaling effects
06
Uncontrolled user reports frequently cite energy, body-composition, and recovery outcomes but cannot establish efficacy

Not approved by regulatory agencies for therapeutic use; wellness and performance claims exceed the available human evidence

Safety Considerations

Monitoring

Fasting glucose and HbA1c
Insulin sensitivity markers
Body composition
Energy levels
Exercise performance

Side Effects

Common

Generally well-tolerated in preclinical studies
Human adverse-event data are too limited for firm risk estimates
Minimal reported side effects

Unknown

Limited long-term human safety data
Potential risks on mitochondrial signaling remain understudied

Contraindications

Not approved for human use
Limited long-term safety data
Not intended to diagnose, treat, or cure any disease

Educational Notice

MOTS-c is an investigational mitochondrial-derived peptide with mostly preclinical support for metabolic-stress and energy-balance biology. It lacks approval from major regulatory bodies for human use, and long-term human safety data remain limited. Potential risks, including unknown long-term effects on mitochondrial signaling, remain understudied, so clinical decisions require qualified medical oversight.

References